Using hypnosis to improve comfort during non-invasive ventilation for COPD and obese patients in intensive care
Official title: HYVIR : Interest of Hypnosis During the Implementation of Non-invasive Ventilation in a Patient With COPD and/or Obesity With a BMI Greater Than 30, Conscious With Acute Respiratory Distress in the Adult Intensive Care Unit
Run by Rennes University Hospital · NCT04220463 · Data updated 2026-11-12
This study is testing if using hypnosis can help make patients with COPD and obesity feel more comfortable during non-invasive ventilation in the intensive care unit.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | Rennes University Hospital Academic / other |
| Locations | 1 site (Rennes, Brittany Region) |
| Status | Recruiting |
| Started | November 20, 2021 |
| Main results expected | November 20, 2025 |
| Study ends | November 20, 2025 |
| Registry record updated | June 24, 2025 |
| Trial ID | NCT04220463 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and over with acute respiratory failure due to COPD and/or obesity (BMI greater than 30) who are conscious and able to provide informed consent.
✕Probably not a fit
Patients in extreme respiratory distress requiring immediate intervention or those with confusional states or severe psychiatric illnesses may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the use of hypnosis as a complementary approach to enhance comfort and tolerance during non-invasive ventilation (NIV) in patients with chronic obstructive pulmonary disease (COPD) and/or obesity in an intensive care setting. The trial focuses on patients experiencing acute respiratory distress, where traditional pharmacological treatments may pose risks. By integrating hypnosis with NIV, the study aims to reduce discomfort and improve the overall effectiveness of the ventilation therapy. Participants will be closely monitored to assess the impact of hypnosis on their ability to tolerate NIV.
Why it matters
Potential benefit: If successful, this approach could significantly improve patient comfort and outcomes during critical respiratory interventions.
How similar studies have gone: While hypnosis has been explored in various medical contexts, this specific application in conjunction with NIV for COPD and obesity is relatively novel and has not been extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Pre-inclusion criteria * Man or woman, aged 18 or over, admitted to medical intensive care * Glasgow score = 15 * Patient with acute respiratory failure decompensating COPD and/or having obesity with a body mass index (BMI) greater than 30 * Patient having given free, informed and written consent * Patient affiliated to a health insurance system Inclusion Criteria: * Glasgow score = 15 * Need during use of non-invasive ventilation Exclusion Criteria: * Procedure to be carried out in extreme urgency (PaCO2 too high and leading to an immediate vital risk, and / or PaO2 too low) on medical decision * Confusional state making hypnosis impossible * Decompensated psychiatric illness * Patient entering with an NIV in place already installed in another department. The subject becomes included again at the end of the treatment with NIV if however he needs it again. * Patient already included in the study during previous non-invasive ventilation * Patient participating in research involving an interventional human person (category 1) on an analgesic / sedative medication * A person of full age subject to legal protection (safeguard of justice, curators, guardianship) or deprived of liberty
Where it's running
-
Rennes University Hospital
Rennes, Brittany Region, France Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Chronic Respiratory Disease Participant Engagement
This study tests whether adults with long-term lung conditions can get comfortable with a clinical trials unit and research team before joining future trials.
-
IOS-based platform to screen, diagnose, and manage COPD and asthma
This study tests an Impulse Oscillometry system to screen for and diagnose COPD and asthma and to help predict flare-ups over about a year, involving adults in China.
-
Targeted NMES to improve breathing and leg/extra muscle strength in COPD
This study tests whether targeted neuromuscular electrical stimulation helps people with COPD see improvements in breathing muscle function and overall muscle strength.
-
AERO-007: a inhaled LABA+LAMA combination for COPD through a nebulizer
This study tests whether a nebulized LABA+LAMA combination can improve lung function in adults with COPD.
-
PBMT with a pulmonary rehab program for COPD patients
A small randomized trial tests whether adding photobiomodulation therapy before exercise in a COPD pulmonary rehab program helps improve functional capacity.
-
Controlled versus standard oxygen therapy for ICU COPD with acute exacerbation
This trial tests whether keeping oxygen levels at 88-92% helps ICU patients with an acute COPD flare more than keeping levels above 94%.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.